Navigation Links
Depomed Reports Third Quarter 2013 Financial Results
Date:11/5/2013

/li>

"In the third quarter, we demonstrated significant revenue growth in both Gralise and Zipsor, and we are excited about the addition of Lazanda at the end of July," said Jim Schoeneck, President and Chief Executive Officer of Depomed. "Our recent sale of our non-core type 2 diabetes royalties, including Glumetza, to PDL BioPharma for $240.5 million gives the company significant flexibility to expand our business through acquisitions of marketed or late stage assets. With over $320 million in cash currently on our balance sheet, pending final tax considerations, and the strength of our core business in pain and neurology, we believe we are well positioned to become a leader in the central nervous system specialty pharmaceutical area."

Third Quarter 2013 Financial ResultsTotal revenues increased to $37.5 million for the third quarter of 2013, compared to $33.3 million for the third quarter of 2012 as indicated below:

 Three Months Ended September 30,20132012Product sales:Gralise$

9,812$

4,758Zipsor6,0224,926Lazanda444—Total product sales 16,2789,684Royalties:Glumetza US$

14,578$

11,603Other844598Total royalty revenue15,42212,201License and other revenue:Glumetza$

760$

1,388Janssen—10,005Mallinckrodt5,000—Other—4Total license and other revenue:5,76011,397Total revenues$

37,460$

33,282 

Selling general and administrative expense was $26.4 million for the third quarter of 2013 compared to $26.8 million for the third quarter of 2012. Third quarter 2013 expenses included two months of selling general and administrative expenses associated with Lazanda.Research and development expense was $1.3 million for the third quarter of 2013 compared to $5.3 million for the third quarter of 2012. The decrease is primarily related the Company ceasing all expenditure on Sefelsa™ during the first quarter of 2013 and the clinical trial expenses a
'/>"/>

SOURCE Depomed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
2. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
3. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
4. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
5. Depomed Reports Second Quarter 2013 Financial Results
6. Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013
7. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
8. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
9. Depomed to Present at Wells Fargo Securities 2013 Healthcare Conference
10. Depomed To Present At Jefferies 2013 Global Healthcare Conference
11. Depomed Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Research and Markets ( ... "Micro Market Monitor: North American Dermatology Diagnostic ... http://photos.prnewswire.com/prnh/20130307/600769 ... which has resulted in fueling the overall demand ... purpose of these dermatology devices is to assist ...
(Date:12/19/2014)... Baptist Health Lexington is the first facility in ... Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status from the ... is the most common cardiac arrhythmia and has become recognized ... to stroke and possible death. More than 5 million patients ... fibrillation and the numbers are rapidly increasing as the population ...
(Date:12/17/2014)... AMSTERDAM and SAN DIEGO , ... PHG ; AEX: PHIA) and Volcano Corporation (NASDAQ: ... and measurement solutions for cardiovascular applications, today announced that they ... agreement, Philips will commence a tender offer to acquire all ... 18.00 per share, or a total equity purchase price of ...
Breaking Medicine Technology:Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... MOUNTAIN VIEW, Calif., April 4, 2011 VIVUS, Inc. (Nasdaq: ... patients treated with the investigational drug QNEXA® for two years ... medications as well as improvements in lipid levels following significant ... placebo group over two years. The data ...
... community pharmacy chain, has revealed that one in four* (24%) of ... has taken or applied medicines which they later discovered were out ... (53%) of people do not always check the expiry date of ... This is worrying considering that nearly one in ...
Cached Medicine Technology:Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3
(Date:12/19/2014)... Sweetdressy.com , a leading wedding dress manufacturer ... of cheap prom dresses for ladies worldwide. The prom ... and clients can buy these dresses at the website ... cool cuts and delicate craftsmanship, and most of them ... Discount shipping costs are available for all of their ...
(Date:12/19/2014)... Branson, Missouri (PRWEB) December 19, 2014 ... a new official world record -- for the first time ... most prestigious record book, Guinness World Records 2015, listing the ... Steepest Wooden Roller Coaster. In additional awards announced this week, ... to See Christmas Lights in the US,” USA Today’s 10Best ...
(Date:12/19/2014)... dress is perfect for any occasion and is a vital ... has unveiled its new selection of evening dresses. Faddish clients ... Customers can view more at its website. , ... and praised by customers for many years. It focuses on ... order to expand its market share, the company has opened ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- The intestinal bacteria that ... ulcerative colitis, may be inherited, researchers report. The ... , could help in efforts to prevent the disease ... colitis, the study authors added. "The intestinal bacteria, ... age can have a big impact on your health ...
(Date:12/19/2014)... News) -- Dense bunches of bacteria called biofilms can be ... finds. The researchers said these biofilms were especially ... presence of these biofilms may represent an increased likelihood of ... a person,s risk for the disease, the researchers said. ... may coat the mucus layer of cells lining the colon, ...
Breaking Medicine News(10 mins):Health News:Cheap Prom Dresses Online Now at Sweetdressy.com 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:Could Bacteria Play a Role in Colon Cancer? 2
... Inc.,publicly announces its offering of patient safety culture and ... clients since 2007,Pascal Metrics rapidly has become a worldwide ... other regulatory requirements, to reduce,costs, and - by making ... failure and errors. , ...
... Technologies(R), Inc.,("Global Med" or the "Company") (OTC ... technology company, today announced that its,European subsidiary, ... marketed as "Hemo Serveur" in France, to ... hospitals, representing 23,000 patient beds. For,Global Med, ...
... Parents and Professionals Shares Experience , Dealing ... , WASHINGTON, Dec. 2 ... equity, diversity, and quality of life for people with ... -- a free peer-to-peer resource directory accessible to ...
... show it could aid shift workers, people affected by jet ... drug tasimelteon helps treat temporary insomnia caused by jet lag ... clinical trials. , The phase II study included 39 people ... mg or 100 mg of tasimelteon, or a placebo. They ...
... ORLANDO, Fla., Dec. 2 MEDai, Inc., headquartered ... added a new module,to its existing suite of ... a population,s compliance to evidence-based medicine,guidelines and alerts ... protocol. The module Risk Navigator Guidelines(TM) provides,real-time ...
... Skipped Medical Care Due to Cost Issues- , ... survey released today by the National Women,s Health Resource Center (NWHRC) ... have failed to seek health care for themselves or their families ... their health has gotten worse over the past five years and ...
Cached Medicine News:Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 2Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 3Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 4Health News:New Website Links People With Disabilities to Peers for Help 2Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care 2Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4
... Mesh is constructed of Bard polypropylene mesh, ... over 40 years. Developed with the world ... Preshaped Mesh takes the guesswork out of ... sugeon performs a Lichtenstein inguinal hernia repair ...
... Kugel patch repair is a minimally invasive, ... a small 4-6 cm incision and requires ... performed through an open, anterior approach that ... anesthesia.,The Modified Kugel patch is a self-expanding ...
... PerFix plug technique, recommended for the ... indirect and direct inguinal hernias, provides ... technique, requiring less overall dissection and ... repair technique. The result is increased ...
... is constructed of knitted filaments of ... that used in PROLENE* Polypropylene Suture, ... The mesh is approximately,0.020 inches thick. ... suture, has been reported to be ...
Medicine Products: